itinai content

  • AI News
  • AI Sales
  • Apple AI
  • Biohacking
  • Clinical Trials
  • Compare
  • Computer Vision
  • DeepSense
  • farma
  • Instruments
  • Management
  • Marketing
  • Marktechpost
  • Open AI
  • resume
  • КП
  • Combining ranibizumab with calcium dobesilate to reduce injection frequency in diabetic macular edema treatment

    18 мая, 2025

    CONCLUSION: Combination therapy with calcium dobesilate and ranibizumab decreased the frequency of intravitreal injections and led to greater improvements in BCVA and CMT compared to ranibizumab alone over 12 months. Both treatments were well-tolerated, with the combination therapy demonstrating a favorable safety profile. →

    Clinical Trials
  • Controlled Intervention Study on Effects of an AI-Based App to Support Wound Care: First Results

    17 мая, 2025

    The KIADEKU project combines datascience and the clinical expertise of wound experts to develop and evaluate an AI-application for incontinence-associated-dermatitis (IAD) and pressure ulcer (PU) wound care. The evaluation study is a controlled, non-randomized clinical trial that investigates the effects of the AI-based system on wound care time, guideline adherence and the task load of… →

    Clinical Trials
  • Garadacimab improves long-term health-related quality of life in patients with hereditary angioedema

    17 мая, 2025

    Background: Hereditary angioedema (HAE) attacks substantially impair health-related quality of life (HRQoL). Current World Allergy Organization and the European Academy of Allergy and Clinical Immunology guidelines goals include complete control and normalization of patients’ lives. Garadacimab (anti-activated factor XII monoclonal antibody) reduced the mean attack rate after first administration in the pivotal phase III (VANGUARD;… →

    Clinical Trials
  • Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimab

    17 мая, 2025

    Background: Hereditary angioedema (HAE) is associated with substantial health-related quality of life (HRQoL) impairments. Complete disease control and life normalization are key treatment goals. In previous studies, garadacimab prevented HAE attacks with a favorable safety profile and HRQoL improvements. Objective: HRQoL was evaluated in patients with HAE receiving garadacimab stratified by attack-free status. Methods: In… →

    Clinical Trials
  • Cost-effectiveness of school integrated pest management and air filtration in students with asthma

    17 мая, 2025

    Background: The cost-effectiveness of school environmental remediation in asthma is not known. The School Inner City Asthma Intervention Study (SICAS2) was a randomized controlled trial that assessed school integrated pest management (IPM) and classroom high efficiency particulate air (HEPA) filtration on asthma morbidity in urban schools. Objective: The objective was to evaluate the cost-effectiveness of… →

    Clinical Trials
  • Outcomes of the linking exercise for advancing daily stress (LEADS) management and resilience randomized pilot trial in African American adolescents and families

    17 мая, 2025

    CONCLUSIONS: This pilot feasibility trial demonstrates the acceptabity and feasibiity of integrating culturally sensitive strength-based interventions for African American families to promote health promotion behaviors and coping. →

    Clinical Trials
  • SLE-DAS enables an accurate definition of severe lupus disease activity: derivation and validation in a post hoc study of anifrolumab phase II and III studies

    17 мая, 2025

    CONCLUSION: The SLE-DAS cut-off for SDA provides an accurate definition of SDA in SLE, with good discriminative power and consistent associations with worse HR-QoL. This SLE-DAS definition enhances disease activity classification and offers a practical tool for guiding treatment decisions in clinical practice, as well as selecting patients with SDA for inclusion in clinical trials. →

    Clinical Trials
  • Insulin for early glycaemic abnormality in children with cystic fibrosis without cystic fibrosis-related diabetes (CF-IDEA): a randomised controlled trial

    17 мая, 2025

    BACKGROUND: People with cystic fibrosis can have impaired insulin secretion and hyperglycaemia before meeting the diagnostic criteria for cystic fibrosis-related diabetes during an oral glucose tolerance test (OGTT). Insulin therapy given to such patients was associated with improved weight and lung function in several small, uncontrolled trials but might increase treatment burden and cause hypoglycaemia.… →

    Clinical Trials
  • Cost-consequence analysis of an e-health intervention to reduce distress in dementia carers: results from the iSupport randomised controlled trial

    17 мая, 2025

    CONCLUSION: Use of iSupport was associated with reduced health and social care resource use costs for carers compared with care-as-usual. Self-guided e-health interventions for dementia carers may have the potential to reduce health and social care resource use and wider societal costs, but evidence relating to their effectiveness and cost-effectiveness is lacking. →

    Clinical Trials
  • AWS Open-Sources Strands Agents SDK to Simplify AI Agent Development

    17 мая, 2025

    AWS Open-Sources Strands Agents SDK to Simplify AI Agent Development Amazon Web Services (AWS) has open-sourced its Strands Agents SDK, aiming to make the development of AI agents more accessible and adaptable across various domains. By following a model-driven approach, the Strands Agents SDK abstracts much of the complexity behind building, orchestrating, and deploying intelligent… →

    AI News
Предыдущая страница
1 … 283 284 285 286 287 … 926
Следующая страница